THE ROLE OF PHARMACOMICROBIOMICS IN THE VARIABILITY OF RESPONSE TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors

  • Sherova Zebo Norbabaevna Asistent
  • Abdikabirov Ramziddin Salakhitdinovich 6th Year Student of the Faculty of Medicine, Pedagogy and Therapy Tashkent State Medical University (Tashkent, Uzbekistan)

DOI:

https://doi.org/10.17605/

Keywords:

Type 2 diabetes, metformin, gut microbiota, pharmacomicrobiomics, individualized response.

Abstract

Type 2 diabetes mellitus (T2DM) shows significant interindividual variability in response to metformin therapy. Gut microbiota composition has been implicated as a modulator of drug efficacy and metabolic outcomes.

Downloads

Published

2026-03-25

Issue

Vol. 7 No. 3 (2026): Wos

Section

Articles

License

Copyright (c) 2026 Web of Scientist: International Scientific Research Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.